Epidural Cervical Spinal Cord Stimulation Safely Enhances Arm Function in Hemiparesis Patients

A feasibility clinical trial published in Nature Medicine on June 4, 2026, indicates that epidural stimulation of the cervical spinal cord may safely improve motor function in individuals living with chronic post-stroke hemiparesis.

The research focused on people with arm hemiparesis, a condition characterized by weakness or partial paralysis on one side of the body following a stroke. The study aimed to determine if stimulating the spinal cord could help restore upper limb movement and reduce associated complications.

According to the findings, the application of epidural stimulation to the cervical spinal cord resulted in improvements in strength and overall function for seven participants involved in the trial.

In addition to gains in strength and functional ability, the authors noted that the therapy improved spasticity, which refers to the muscle stiffness and involuntary contractions often experienced by stroke survivors.

The trial was designed as a feasibility study, meaning its primary goal was to assess whether the intervention could be performed safely and if the methodology was viable for larger-scale testing. The researchers concluded that the stimulation was administered safely among the study group.

The study highlights the potential of neuromodulation—specifically targeting the spinal cord—as a biomedical approach to treating chronic motor impairments that persist long after the initial stroke event.